- Home
- CMMB vs ITOC Comparison
CMMB vs ITOC Comparison
Compare CMMB & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMMB | ITOC |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2M | 9.4M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | CMMB | ITOC |
|---|---|---|
| Price | $1.66 | $0.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $26.50 | N/A |
| AVG Volume (30 Days) | 74.1K | ★ 3.9M |
| Earning Date | 03-02-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $305,215.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.54 | $0.39 |
| 52 Week High | $8.76 | $32.00 |
Technical Indicators
Market Signals| Indicator | CMMB | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 38.62 | N/A |
| Support Level | $1.54 | N/A |
| Resistance Level | $1.85 | N/A |
| Average True Range (ATR) | 0.14 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 36.47 | 0.00 |
Price Performance
Historical ComparisonAbout CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About ITOC iTonic Holdings Ltd Class A Ordinary Shares
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.